Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease
Open Access
- 1 July 2019
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 12 (7) , dmm038737
Abstract
Skeletal muscle wasting and atrophy is one of the more severe clinical impairments resulting from the progression of Huntington's disease (HD). Mitochondrial dysfunction may play a significant role in the etiology of HD, but the specific condition of mitochondria in muscle has not been widely studied during the development of HD. To determine the role of mitochondria in skeletal muscle during the early stages of HD, we analyzed quadriceps femoris muscle from 24-, 36-, 48- and 66-month-old transgenic minipigs that expressed the N-terminal portion of mutated human huntingtin protein (TgHD) and age-matched wild-type (WT) siblings. We found altered ultrastructure of TgHD muscle tissue and mitochondria. There was also significant reduction of activity of citrate synthase and respiratory chain complexes (RCCs) I, II and IV, decreased quantity of oligomycin-sensitivity conferring protein (OSCP) and the E2 subunit of pyruvate dehydrogenase (PDHE2), and differential expression of optic atrophy 1 protein (OPA1) and dynamin-related protein 1 (DRP1) in the skeletal muscle of TgHD minipigs. Statistical analysis identified several parameters that were dependent only on HD status and could therefore be used as potential biomarkers of disease progression. In particular, the reduction of biomarker RCCII subunit SDH30 quantity suggests that similar pathogenic mechanisms underlie disease progression in TgHD minipigs and HD patients. The perturbed biochemical phenotype was detectable in TgHD minipigs prior to the development of ultrastructural changes and locomotor impairment, which become evident at the age of 48 months. Mitochondrial disturbances may contribute to energetic depression in skeletal muscle in HD, which is in concordance with the mobility problems observed in this model. This article has an associated First Person interview with the first author of the paper.Keywords
Funding Information
- Ministry of Education, Youth and Sports (7F14308, LO1609, LD15099)
- Charles University (PROGRES Q26/LF1/3, UNCE 204064)
- the Czech Science Foundation (GAČR 14-36804G)
This publication has 64 references indexed in Scilit:
- Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's diseaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative diseaseHuman Molecular Genetics, 2011
- Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's diseaseMovement Disorders, 2010
- Mitochondrial fission and remodelling contributes to muscle atrophyThe EMBO Journal, 2010
- Abnormal morphology of peripheral cell tissues from patients with Huntington diseaseJournal of Neural Transmission, 2009
- Huntington’s Disease and Mitochondrial DNA Deletions: Event or Regular Mechanism for Mutant Huntingtin Protein and CAG Repeats Expansion?!Cellular and Molecular Neurobiology, 2007
- Mitochondrial NAD+‐linked State 3 respiration and complex‐I activity are compromised in the cerebral cortex of 3‐nitropropionic acid‐induced rat model of Huntington’s diseaseJournal of Neurochemistry, 2007
- Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesNature Neuroscience, 2002
- Lactate oxidative capacity in different types of muscleBiochemical and Biophysical Research Communications, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976